Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seethal A Jacob

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|May 17, 2017
No improvement in clinical trial enrollment for adolescents and young adults with cancer at a children's hospitalSeethal A Jacob, Peter H Shaw
Pediatric Blood & Cancer|August 16, 2021
Importance of sickle cell trait counseling for adolescents and young adultsSeethal A Jacob, Emily Riehm Meier
BMJ Quality & Safety|July 27, 2023
Moving the needle: using quality improvement to address gaps in sickle cell careSeethal A Jacob, Jennifer C Yui
Hematology. American Society of Hematology. Education Program|December 5, 2025
Optimizing the right time to start sickle cell therapiesOlufunke Y Martin, Seethal A Jacob
The Lancet. Child & Adolescent Health|October 20, 2023
The evolving treatment landscape for children with sickle cell diseaseSeethal A Jacob, Ravi Talati, Julie Kanter
Journal of Pediatric Hematology/Oncology|May 11, 2021
Maintenance of an Immunogenic Response to Pneumococcal Vaccination in Children With Sickle Cell DiseaseMahvish Q Rahim, Alexandria M Arends, Seethal A Jacob
Journal of Telemedicine and Telecare|November 8, 2019
A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved areaSeethal A Jacob, Aaron E Carroll, William E Bennett
Blood Advances|March 14, 2025
Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell diseaseKristine Anne Karkoska, Seethal A Jacob, Patrick T McGann
Pediatric Blood & Cancer|November 7, 2024
Osteopathic Manipulative Treatment: A Safe and Feasible Adjunct in Sickle Cell Disease Pain ManagementAmber Brown, Derrick Goubeaux, Seethal A Jacob, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|May 13, 2022
Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for ChildrenAlexandria M Arends, Anne Perez, Christina Wilder, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|May 17, 2017
No improvement in clinical trial enrollment for adolescents and young adults with cancer at a children's hospitalSeethal A Jacob, Peter H Shaw
Pediatric Blood & Cancer|August 16, 2021
Importance of sickle cell trait counseling for adolescents and young adultsSeethal A Jacob, Emily Riehm Meier
BMJ Quality & Safety|July 27, 2023
Moving the needle: using quality improvement to address gaps in sickle cell careSeethal A Jacob, Jennifer C Yui
Hematology. American Society of Hematology. Education Program|December 5, 2025
Optimizing the right time to start sickle cell therapiesOlufunke Y Martin, Seethal A Jacob
The Lancet. Child & Adolescent Health|October 20, 2023
The evolving treatment landscape for children with sickle cell diseaseSeethal A Jacob, Ravi Talati, Julie Kanter
Journal of Pediatric Hematology/Oncology|May 11, 2021
Maintenance of an Immunogenic Response to Pneumococcal Vaccination in Children With Sickle Cell DiseaseMahvish Q Rahim, Alexandria M Arends, Seethal A Jacob
Journal of Telemedicine and Telecare|November 8, 2019
A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved areaSeethal A Jacob, Aaron E Carroll, William E Bennett
Blood Advances|March 14, 2025
Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell diseaseKristine Anne Karkoska, Seethal A Jacob, Patrick T McGann
Pediatric Blood & Cancer|November 7, 2024
Osteopathic Manipulative Treatment: A Safe and Feasible Adjunct in Sickle Cell Disease Pain ManagementAmber Brown, Derrick Goubeaux, Seethal A Jacob, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|May 13, 2022
Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for ChildrenAlexandria M Arends, Anne Perez, Christina Wilder, et al.
Pageof 5